NCT04235257View on ClinicalTrials.gov

Intradermal, Fractional Dose of HPV Vaccines:

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HPV InfectionHPV Vaccine
Interventions
BIOLOGICAL

HPV vaccine

Gardasil 9 Bivalent HPV VLP Vaccine, one-fifth dose Nonavalent HPV VLP Vaccine, one-fifth dose

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

All Listed Sponsors
lead

University of Washington

OTHER